Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
15.79
+0.23 (1.48%)
Jul 21, 2026, 1:09 PM EDT - Market open
Caris Life Sciences Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Caris Life Sciences stock has a consensus rating of "Buy" and an average price target of $27. The average 1-year stock price forecast is 70.99% higher than the current stock price, while the lowest is $21 (+33.00%) and the highest is $36 (+127.99%).
Price Target: $27 (+70.99%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Caris Life Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 10 | 10 | 9 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $31 → $30 | Buy | Maintains | $31 → $30 | +89.99% | Jul 15, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $28 → $23 | Buy | Reiterates | $28 → $23 | +45.66% | Jul 13, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $30 → $25 | Buy | Maintains | $30 → $25 | +58.33% | Jul 6, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $27 | Buy | Maintains | $27 | +70.99% | Jul 2, 2026 |
| BTIG | BTIG | Buy Reiterates $32 | Buy | Reiterates | $32 | +102.66% | Jul 2, 2026 |
Financial Forecast
Revenue This Year
1.00B
from 812.03M
Increased by 23.29%
Revenue Next Year
1.20B
from 1.00B
Increased by 19.68%
EPS This Year
0.13
from -0.41
EPS Next Year
0.36
from 0.13
Increased by 173.94%
EPS and Forward PE are based on non-GAAP adjusted numbers.